Medicine and Dentistry
Patient
100%
COVID-19
45%
Plasma
32%
Combination Therapy
26%
Transfusion
24%
Apheresis
20%
Major Bleeding
19%
Von Willebrand Factor
18%
Transfusion Medicine
18%
Prothrombin Complex
18%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Therapeutic Procedure
17%
Inpatient
17%
Bleeding
15%
Receptor Binding
14%
Blood Transfusion
14%
Blood
14%
Diseases
13%
Erythrocyte
13%
Heart Surgery
13%
Rivaroxaban
13%
Apixaban
13%
Monitoring
12%
Mortality
12%
Association
12%
Blood Stasis
11%
Analysis
11%
Hospital
10%
Blood Clotting Factor 10a Inhibitor
10%
Laboratory
9%
Neutrophil
9%
Ticagrelor
9%
Parasite (Microbiology)
9%
Sulfhemoglobinemia
9%
Biological Therapy
9%
Infection
8%
Evaluation Study
8%
Acute Kidney Injury
8%
Fibrinogen Concentrate
7%
Pathology
7%
Cyclic Adenosine Monophosphate
7%
Central Venous Catheter
7%
Virus
7%
Antithrombotic
7%
Donor
6%
Experience
6%
Platelet
6%
Aptamer
6%
Liver Transplantation
6%
Assay
5%
Pharmacology, Toxicology and Pharmaceutical Science
Apixaban
40%
Rivaroxaban
31%
Blood Clotting Factor 10a Inhibitor
21%
Thrombosis
16%
Bleeding
12%
Acute Kidney Failure
11%
Anticoagulant Agent
11%
Andexanet Alfa
9%
Toxic Injury
9%
Venous Thromboembolism
8%
End Stage Renal Disease
6%
Mortality
6%
Symptom
6%
Aptamer
6%
Monoclonal Antibody
6%
Amphotericin B
6%
Thromboembolism
5%
Diseases
5%
Replacement Therapy
5%
Biochemistry, Genetics and Molecular Biology
Soluble Adenylyl Cyclase
27%
Hemostasis
9%
Pseudomonas aeruginosa
9%
Mitochondrion
9%
Annexin
9%
Parasite
9%
Coronavirinae
9%
Binding Domain
9%
Von Willebrand Factor
9%
Automation
9%
Platelet
9%
Lysozyme
9%
Regulatory Mechanism
8%
Mitochondrial Protein
8%
Adenylyl Cyclase
8%
Cyclic Adenosine Monophosphate
7%
Cytochrome Oxidase
7%
Development
7%
Protein Kinase A
7%
Signal Transduction
6%
Phosphorylation
6%
Aptamer
6%
Virulence
6%
Animal
5%
Small Molecule
5%
Second Messenger System
5%
